Abstract:BACKGROUND:The role of histone deacetylases 6 (HDAC6) has been elucidated in various neurodegenerative diseases. However, the effect of HDAC6 on retinal degenerative processes remains unknown. The aim of this study was to elucidate the potential role of HDAC6 in the retinal ischaemia and reperfusion (I/R) injury model.METHODS:The retinal pathological lesion was evaluated by haematoxylin and eosin (H&E) staining. HDAC expression or activity was detected by immunohistochemistry, Western blotting assays or colorimetric assays. The expression of apoptotic- and autophagic- related proteins were quantified by Western blotting and RT-PCR. The expression of peroxiredoxin 2 (Prx2) was determined by RT-PCR and ELISA. The levels of acetylated α-tubulin and acetylated histone 3 in the retina were assayed by Western blotting.RESULTS:We found that I/R-induced reduction of the retinal thickness was ameliorated, and the survival of RGCs was increased by the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) as well as by tubacin (an HDAC6 selective inhibitor). The decreased expression of THY (thymus cell antigen) in the I/R-induced retinas was also reversed by TSA and tubacin. Elevated HDAC6 expression and activity in the retina from I/R injury were significantly inhibited by tubacin, which also attenuated I/R-mediated apoptosis by decreasing TUNEL-positive RGCs and Bax expression and increasing Bcl-2 expression. Additionally, tubacin increased the expression of autophagy-related gene Beclin 1 and microtubule-associated protein 1 light chain 3B (LC3B) and the levels of Prx2. Furthermore, the protective effect of tubacin was associated with acetylated α-tubulin and was independent of acetylated histone 3.CONCLUSIONS:Our findings suggest that tubacin exhibits neuroprotective effects after I/R retinal injury, and HDAC6 may be a potential therapeutic target for the retinal neurodegenerative disease of glaucoma.

HDAC6 Inhibition Protects Against OGDR-Induced Golgi Fragmentation and Apoptosis

HDAC9 Deficiency Upregulates Cgmp-Dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke

Involvement of HDAC6 in Ischaemia and Reperfusion-Induced Rat Retinal Injury

Upregulation of MDH1 acetylation by HDAC6 inhibition protects against oxidative stress-derived neuronal apoptosis following intracerebral hemorrhage

Selective HDAC6 inhibition protects against blood–brain barrier dysfunction after intracerebral hemorrhage

Selective HDAC6 Inhibitor TubA Offers Neuroprotection after Intracerebral Hemorrhage Via Inhibiting Neuronal Apoptosis.

Hsp20 Protects Against Oxygen-Glucose Deprivation/Reperfusion-Induced Golgi Fragmentation and Apoptosis Through Fas/Fasl Pathway

Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

GDF15 regulated by HDAC2 exerts suppressive effects on oxygen-glucose deprivation/reoxygenation-induced neuronal cell pyroptosis via the NLRP3 inflammasome

Cdk1 Protects Against Oxygen-Glucose Deprivation and Reperfusion-Induced Golgi Fragmentation and Apoptosis Through Mediating GM130 Phosphorylation.

Geranylgeranylacetone Protects Against Cerebral Ischemia and Reperfusion Injury: HSP90 and Enos Phosphorylation Involved.

HDAC6 Inhibition Alleviates Ischemia- and Cisplatin-Induced Acute Kidney Injury by Promoting Autophagy

HDAC3 Inhibition Prevents Oxygen Glucose Deprivation/reoxygenation‐induced Transendothelial Permeability by Elevating PPARγ Activity in Vitro

Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia–reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain

Molecular mechanism of HDAC6-mediated pyroptosis in neurological function recovery after cardiopulmonary resuscitation in rats

HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury.

Genetic deletion or pharmacologic inhibition of HDAC6 protects the heart against ischemia/reperfusion injury by limiting TNFα-induced mitochondrial injury in experimental diabetes

Inhibition of HDAC6 Increases Acetylation of Peroxiredoxin1/2 and Ameliorates 6-OHDA Induced Dopaminergic Injury

Genetic Deletion or Pharmacologic Inhibition of Histone Deacetylase 6 Protects the Heart Against Ischaemia/reperfusion Injury by Limiting Tumour Necrosis Factor Alpha-Induced Mitochondrial Injury in Experimental Diabetes.

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.

Degradation of histone deacetylase 6 alleviates ROS-mediated apoptosis in renal ischemia-reperfusion injury